Category: News Well
Content tagged to appear in the middle column of the home page
Olympus says it agreed to pay $92 million to settle a pair of civil lawsuits brought over the 2001 accounting scandal that nearly brought the company down.
Armed with a recent $30 million funding found, Obalon Therapeutics launches a pivotal trial for its ingestible weight loss balloon.
California's Obalon Therapeutics said it launched a pivotal trial set for as many as 15 sites across the U.S. that will test its ingestible, gas-filled weight-loss balloon.
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
The FDA grants a humanitarian device exemption for a micro-pacemaker designed to be implanted in a fetus.
Comparative sizes of fetal
and adult pacemakers.
Click image to enlarge.
Researchers at Children's Hospital Los Angeles and the University of Southern California said the FDA granted a humanitarian device exemption for the fetal micro-pacemaker they designed.
Stryker launches the Bio4 bone-allograft product made by Osiris Therapeutics at the recent American Academy Of Orthopaedic Surgeons meeting in Las Vegas.
The U.S. Senate delays a vote on the so-called 'doc fix' bill to change the way Medicare pays doctors, which passed the House earlier this week.
(Reuters) — The U.S. Senate will wait more than 2 weeks before acting on a bill to permanently fix the flawed formula for reimbursing Medicare physicians, after an April 1 deadline to start a 21% cut in payment rates.